Abstract
A one-trial passive avoidance test in the mouse, in which drugs were injected intraperitoneally immediately after the shocked acquisition trial, was used. The effects of enhancing central cholinergic transmission on retention of passive avoidance was investigated using secoverine, which blocks muscarinic autoreceptor-mediated inhibition of acetylcholine release, and using physostigmine, an acetylcholinesterase inhibitor. Secoverine (1.0–5.0 mg/kg) and physostigmine (0.1–0.4 mg/kg) were found to improve retention of the avoidance response measured 24 h after acquisition. These effects were augmented when the two drugs were given in combination. In contrast, atropine (5.0 mg/kg) tended to impair retention of passive avoidance and blocked the facilitatory effects of physostigmine. The results support the hypothesis of a novel approach to treatment of memory disorders based on blockade of muscarinic autoreceptors, to augment central cholinergic activity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson PS, Haubrich D (1981) Memory and learning. Annu Rep Med Chem 16:51–60
Bammer G (1982) Pharmacological investigations of neurotransmitter involvement in passive avoidance responding: A review and some new results. Neurosci Biobehav Rev 6:247–296
Baratti CM, Huygens P, Mino J, Merlo A, Gardella J (1979) Memory facilitation with posttrial injection of oxotremorine and physostigmine in mice. Psychopharmacology 64:85–88
Bartus R, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–417
Birdsall NJM, Hulme EC (1983) Muscarinic receptor subclasses. TIPS 4:459–463
Caulfield MP, Higgins GA, Straughan DW (1983) Central administration of the muscarinic receptor subtype-selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouse. J Pharm Pharmacol 35:131–132
Flood JF, Smith GE, Cherkin A (1984) Memory retention: effect of prolonged cholinergic stimulation in mice. Pharmacol Biochem Behav 20:161–163
Flood JF, Smith GE, Cherkin A (1985) Memory enhancement: supra-additive effect of subcutaneous cholinergic drug combinations in mice. Psychopharmacology 86:61–67
Haroutunian V, Barnes E, Davis KL (1985) Cholinergic modulation of memory in rats. Psychopharmacology 87:266–271
Hunter B, Zornetzer SF, Jarvik ME, McGaugh JL (1977) Modulation of learning and memory: effects of drugs influencing neurotransmitters. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 8. Plenum, New York, pp 531–577
Johns CA, Greenwald BS, Mohs RC, Davis KL (1983) The cholinergic treatment strategy in aging and senile dementia. Psychopharmacol Bull 19:185–197
Marchi M, Raiteri M (1985) Differential antagonism by dicyclomine, pirenzepine and secoverine at muscarinic receptor subtypes in the rat frontal cortex. Eur J Pharmacol 107:287–288
Prado-Alcala RA, Fernandez-Samblancat M, Solodkin-Herrera M (1985) Injections of atropine into the caudate nucleus impair the acquisition and the maintenance of passive avoidance. Pharmacol Biochem Behav 22:243–247
Siegel S (1956) Non-parametric statistics for the behavioural sciences. McGraw-Hill, New York
Warburton DM, Wesnes K (1984) Drugs as research tools in psychology: cholinergic drugs and information processing. Neuropsychobiology 11:121–132
Zwagemakers JMA, Claassen V (1980) Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Arzneimittelforsch/Drug Res 30:1517–1526
Zwagemakers JMA, Claassen V (1981) Secoverine selectively antagonises muscarinic effects at various in vivo preparations. Eur J Pharmacol 71:165–168
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gower, A.J. Enhancement by secoverine and physostigmine of retention of passive avoidance response in mice. Psychopharmacology 91, 326–329 (1987). https://doi.org/10.1007/BF00518185
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00518185